Natural history and metabolic consequences of morbid obesity for patients denied coverage for bariatric surgery

被引:32
|
作者
Al Harakeh, Ayman B. [3 ]
Burkhamer, Kyle J. [2 ]
Kallies, Kara J. [2 ]
Mathiason, Michelle A. [2 ]
Kothari, Shanu N. [1 ]
机构
[1] Gundersen Lutheran Hlth Syst, Dept Gen Surg, La Crosse, WI 54601 USA
[2] Gundersen Lutheran Med Fdn, Dept Surg Res, La Crosse, WI USA
[3] Gundersen Lutheran Med Fdn, Dept Med Educ, La Crosse, WI USA
关键词
Laparoscopic gastric bypass; Insurance; Denial; Co-morbidities; Morbid obesity; GASTROESOPHAGEAL-REFLUX DISEASE; Y GASTRIC BYPASS; WEIGHT-LOSS; SURVIVAL; DENIALS; IMPACT;
D O I
10.1016/j.soard.2010.08.012
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Patients satisfying the National Institutes of Health criteria and deemed appropriate candidates often do not undergo bariatric surgery for insurance-related reasons. Our objective was to explore the natural history of these patients compared with that of those who underwent laparoscopic Roux-en-Y gastric bypass (LRYGB). Methods: The medical records of the patients evaluated for LRYGB from 2001 to 2007 were retrospectively reviewed. The presence of co-morbidities was assessed at the initial evaluation and within a 3-year follow-up period for patients who had undergone LRYGB and those denied surgery. The statistical analysis included chi-square tests. Results: A total of 189 patients were in the denied cohort and 587 in the LRYGB cohort. The age, gender, and body mass index were similar between the 2 cohorts at the initial evaluation. The percentage of patients with a diagnosis of a co-morbidity in the denied and LRYGB cohorts at the initial evaluation was 20% and 25% with diabetes mellitus, 51% and 43% with hypertension, 20% and 22% with obstructive sleep apnea, 34% and 24% with lipid disorders, and 62% and 49% with gastroesophageal reflux disease, respectively. The body mass index at the initial evaluation and during follow-up was 47.3 and 46.8 kg/m(2) in the denied cohort (n = 165, P = .236) and 48.5 and 30.5 kg/m(2) in the LRYGB cohort (n = 544, P < .001), respectively. During the follow-up period, a greater incidence of new-onset diabetes (P < .001), hypertension (P < .001), obstructive sleep apnea (P < .001), gastroesophageal reflux disease (P < .001), and lipid disorders (P < .001) was observed in the denied cohort. Conclusion: Patients denied LRYGB had a greater incidence of new co-morbidities diagnosed within a short follow-up period, without a significant change in their body mass index. (Surg Obes Relat Dis 2010;6:591-596.) (C) 2010 American Society for Metabolic and Bariatric Surgery. All rights reserved.
引用
收藏
页码:591 / 596
页数:6
相关论文
共 50 条
  • [31] Unintended consequences for patients denied bariatric surgery: a 12-year follow-up
    Kappus, Mojdeh S.
    Phillips, Blaine T.
    Zenquis, Nicholas
    Larionova, Evgeniya
    Cudmore, Jaime
    Jones, Daniel B.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2020, 16 (10) : 1458 - 1462
  • [32] Efficacy of probiotics in patients with morbid obesity undergoing bariatric surgery: a systematic review and meta-analysis
    Swierz, Mateusz J.
    Storman, Dawid
    Staskiewicz, Wojciech
    Gorecka, Magdalena
    Jasinska, Katarzyna W.
    Swierz, Aleksandra M.
    Tobola, Paulina
    Skuza, Anna
    Bala, Malgorzata M.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2020, 16 (12) : 2105 - 2116
  • [33] Economic considerations for bariatric surgery and morbid obesity
    Frezza, Eldo E.
    Wacthell, Mitchell
    Ewing, Bradley
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2009, 1 : 79 - 83
  • [34] Contribution of Bariatric Surgery to the Comprehension of Morbid Obesity
    Picard Marceau
    Obesity Surgery, 2005, 15 : 3 - 10
  • [35] Contribution of bariatric surgery to the comprehension of morbid obesity
    Marceau, P
    OBESITY SURGERY, 2005, 15 (01) : 3 - 10
  • [36] Vitamin D status and supplementation in morbid obesity before and after bariatric surgery
    Bacci, Vincenzo
    Silecchia, Gianfranco
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (06) : 781 - 794
  • [37] Metabolic consequences of bariatric surgery
    Lynch, Raymond J.
    Eisenberg, Dan
    Bell, Robert L.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (08) : 659 - 668
  • [38] Cost-Effectiveness Analysis of Bariatric Surgery for Morbid Obesity
    Alsumali, Adnan
    Eguale, Tewodros
    Bairdain, Sigrid
    Samnaliev, Mihail
    OBESITY SURGERY, 2018, 28 (08) : 2203 - 2214
  • [39] Is the morbid obesity surgery profitable in times of crisis? A cost-benefit analysis of bariatric surgery
    Sanchez-Santos, Raquel
    Sabench Pereferrer, Fatima
    Estevez Fernandez, Sergio
    del Castillo Dejardin, Daniel
    Vilarrasa, Nuria
    Frutos Bernal, Dolores
    Carlos Ruiz de Adana, Juan
    Masdevall Noguera, Carlos
    Torres Garcia, Antonio
    CIRUGIA ESPANOLA, 2013, 91 (08): : 476 - 484
  • [40] Bariatric surgery is an effective treatment for morbid obesity
    Schigt, A.
    Gerdes, V. E. A.
    Cense, H. A.
    Berends, F. J.
    van Dielen, F. M. H.
    Janssen, I.
    van der Laar, A.
    van Wagensveld, B. A.
    Romijn, J. A.
    Serlie, M. J.
    NETHERLANDS JOURNAL OF MEDICINE, 2013, 71 (01) : 4 - 9